A Smartphone Application for Neurology and Telemedicine (NeuroVision)
NeuroVision™: A Smartphone Application for Neurology and Telemedicine
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Bhawna Shiwani, MS
- Phone Number: (508)545-8217
- Email: bshiwani@altecresearch.com
Study Contact Backup
- Name: Serge Roy, ScD, PT
- Phone Number: (508)545-8235
- Email: sroy@delsys.com
Study Locations
-
-
Massachusetts
-
Natick, Massachusetts, United States, 01760
- Recruiting
- Altec Inc.
-
Contact:
- Bhawna Shiwani, MS
- Phone Number: 508-545-8217
- Email: bshiwani@altecresearch.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or Female;
- 35 years of age or older;
- Physician-diagnosed Parkinson's disease or other movement disorder such as Essential Tremor or Dystonia;
- One or more mild to moderate motor symptoms of PD (tremor, bradykinesia, akinesia, Parkinsonian gait);
- Hohn and Yahr (Stage I-III);
- Independent ambulator - walker or cane allowed;
- Referring neurologist indicates that prospective subject is not at high fall risk and can safely participate in the study;
- Have participated in prior telehealth visits using videoconferencing app;
- Have used a smartphone in past to record videos;
- Able to provide his/her written informed consent to participate in the study as stated in the informed consent document;
- American-English speaking; able to follow directions in English;
- Normal hearing.
Exclusion Criteria:
- Inability to understand spoken English or follow simple instructions;
- Inability to provide written informed consent.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Parkinson's disease (PD)
Individuals with mild to severe movement disorder symptoms of Parkinson's disease
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tremor Duration
Time Frame: 2 minute
|
Duration in seconds of resting tremor in the hands obtained using the NeuroVision prototype while the subject is sitting at rest.
|
2 minute
|
|
Tremor Amplitude
Time Frame: 2 minute
|
Amplitude in centimeters of resting tremor in the hands obtained using the NeuroVision prototype while the subject is sitting at rest.
|
2 minute
|
|
Parkinsonian Gait - Step Length
Time Frame: 5 minute
|
Step length in centimeters obtained using the NeuroVision prototype while the subject is walking.
|
5 minute
|
|
Parkinsonian Gait - Step Time
Time Frame: 5 minute
|
Step time in seconds obtained using the NeuroVision prototype while the subject is walking.
|
5 minute
|
|
Parkinsonian Gait - Step Variability
Time Frame: 5 minute
|
Step variability in centimeters obtained using the NeuroVision prototype while the subject is walking.
|
5 minute
|
|
Bradykinesia Finger Tap Duration
Time Frame: 2 minute
|
Duration in seconds of a finger tapping task obtained using the NeuroVision prototype while the subject opens and closes their hand as rapidly as possible.
|
2 minute
|
|
Bradykinesia Finger Tap Amplitude
Time Frame: 2 minute
|
Amplitude in centimeters of a finger tapping task obtained using the NeuroVision prototype while the subject opens and closes their hand as rapidly as possible.
|
2 minute
|
|
Bradykinesia Foot Tap Duration
Time Frame: 2 minute
|
Duration in seconds of a foot tapping task obtained using the NeuroVision prototype while the subject taps their toes on the floor as rapidly as possible.
|
2 minute
|
|
Bradykinesia Foot Tap Amplitude
Time Frame: 2 minute
|
Amplitude in centimeters of a foot tapping task obtained using the NeuroVision prototype while the subject taps their toes on the floor as rapidly as possible.
|
2 minute
|
|
Bradykinesia Foot Stomping Duration
Time Frame: 2 minute
|
Duration in seconds of a foot stomping task obtained using the NeuroVision prototype while the subject lifts and lowers their foot on the floor as rapidly as possible.
|
2 minute
|
|
Bradykinesia Foot Stomping Amplitude
Time Frame: 2 minute
|
Amplitude in centimeters of a foot stomping task obtained using the NeuroVision prototype while the subject lifts and lowers their foot on the floor as rapidly as possible.
|
2 minute
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Bhawna Shiwani, MS, Senior Research Scientist
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- R43NS125709 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.